30 Day Trial

SeaSpine 2Q18 Revenue +7% vs. 2Q17


SeaSpine announced 2Q18 revenue of US $36.4MM, +6.5% vs. 2Q17, and 1H18 revenue of $69.6MM, +5.3% vs. 1H17. This is the company’s highest quarterly growth rate since its spinoff from Integra LifeSciences in 2015.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.